OraSure Technologies, Inc.

NASDAQ:OSUR

Medical - Instruments & Supplies

Healthcare
$3.59 -3.47%

-$0.16 today

Market cap
$247.88M
Beta
1.01
P/E (TTM)
-4.0
EPS (TTM)
-$1.08
52W Low $2.08High $4.58

Volume 0.49M

Average 0.61M

OSUR Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

OraSure Technologies, Inc.NASDAQ: OSUR

Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Financing cash flow growth accelerates

Q1 FY2026 financing cash flow of $6.28M (cash outflow) rose 559.2% year over year, ahead of the +481.2% change in trailing-twelve-month financing cash flow. Sequentially, it rose 22.8% from the prior quarter. Over 3 fiscal years it compounded at -83.6% a year.

Context

  • Financing cash flow amounted to 0.0% of revenue in FY2025, down 2.2 pp from a year earlier.
  • Financing cash flow grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +559.2% holds above the trailing-twelve-month pace of +481.2%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$6.28M+22.8% QoQ
Last fiscal yearDec 2025
-$16.94K-99.6% YoY
LTMMar 2026
-$22.27M+481.2% YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+559.2%——
1 year-99.6%——
3-year CAGR-83.6%——
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

USD · from the cash flow

Latest · FY2025
(16.94K) USD
Year-over-year change
+99.6%

Financing Cash Flow vs competitors

How OSUR compares with its peers on the latest reported figures

  • Peers report in different currencies, so financing cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +481.2% is the highest of 8, against a peer median of -7.2%.
  • Financing cash flow amounts to 19.7% of revenue for OSUR, versus a peer median of 124.2%.
OSUR Competitors
Financing Cash Flow for OSUR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CATXPerspective Therapeutics, Inc.LTM Mar 2026$164.7M USD+23.8%+468.8%26649.8%
TARAProtara Therapeutics, Inc.LTM Mar 2026$82.13M USD-42.0%——
PROFProfound Medical Corp.LTM Mar 2026$42.24M USD+23.6%+81.2%223.8%
NYXHNyxoah S.A.LTM Mar 2026€38.51M EUR-50.0%—236.0%
PREPrenetics Global LimitedLTM Mar 2026$24.27M USD—-36.0%21.3%
OSUROraSure Technologies, Inc.LTM Mar 2026$22.27M USD+481.2%-83.6%19.7%
NTHINeonc Technologies Holdings, Inc.LTM Mar 2026$16.91M USD———
STIMNeuronetics, Inc.LTM Mar 2026$11.3M USD-7.2%+457.4%7.4%
UTMDUtah Medical Products, Inc.LTM Mar 2026$9.22M USD-61.7%+31.0%24.6%
NAUTNautilus Biotechnology, Inc.LTM Mar 2026$1.3M USD+41.9%-27.5%—
Peer median (excluding OSUR) —-7.2%+56.1%124.2%

Competitors are the stored peer set for OSUR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(23M)(17.93M)53.66M(19.5M)(68.73K)
Depreciation & Amortization12.5M15.54M20.94M10.87M10.19K
Deferred Income Tax1.03M(1.65M)102K(657K)(103)
Stock-Based Compensation7.81M11.62M10.73M11.92M10.15K
Change in Working Capital(38.44M)(70.56M)45.76M18.82M(6.8M)
Accounts Receivables(6.45M)(25.16M)31.12M15.87M1.95M
Inventory(27.94M)(43.05M)48.23M13.1M3.56M
Accounts Payables3.23M3.96M(26.98M)(7.58M)(1.72M)
Other Working Capital(7.28M)(6.32M)(6.61M)(2.57M)(10.59M)
Other Non-Cash Items4.72M15.79M10.4M5.92M6.8M
Operating Cash Flow(35.38M)(47.2M)141.58M27.37M(49.02K)
Capital Expenditures(48.12M)(63.91M)(10.3M)(3.8M)(4.2K)
Acquisitions (Net)0121K0(5.04M)(3.61K)
Purchases of Investments(25.82M)(22.87M)(74.65M)(53.24M)0
Sales of Investments67.93M47.42M102.44M53.05M0
Other Investing Activities513K60.33M48.67M(30M)1K
Investing Cash Flow(5.5M)21.09M66.15M(39.03M)(6.81K)
Debt Repayment(686K)(1.38M)(1.35M)(842K)(61K)
Common Stock Issued00000
Common Stock Repurchased(2.11M)(2.25M)(1.9M)(3.55M)(15.04M)
Dividends Paid00000
Other Financing Activities(18K)(193K)223K214K15.08M
Financing Cash Flow(2.82M)(3.83M)(3.02M)(4.18M)(16.94K)
Effect of Forex Changes(340K)(2.84M)1.71M(6.82M)4.29K
Net Change in Cash(44.04M)(32.78M)206.43M(22.64M)(68.49K)
Free Cash Flow(83.5M)(111.11M)131.28M23.58M(53.22K)

OraSure Technologies, Inc.

NASDAQ:OSUR

Intrinsic Alpha fair value

Locked

Current Price

$3.59

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.